Breaking News Instant updates and real-time market news.

CLVS

Clovis

$34.76

-0.59 (-1.67%)

10:13
10/05/16
10/05
10:13
10/05/16
10:13

Clovis early strength attributed to renewed takeover speculation

Shares of Clovis Oncology (N) have built upside momentum in early trading, with market participants attributing the strength to renewed takeover speculation, according to trading contacts. The Fly, in fulfilling its mission of explaining stock movement, often comes across the many unconfirmed rumors being passed through trading desks and social media platforms. On the occasion that rumors or speculation appear on The Fly's news feed, it should be viewed not as giving credence to the conjecture, rather as simply highlighting its impact on the stock prices of the companies involved. Shares of Clovis have rallied about 3% to $35.79 in early trading.

  • 06

    Nov

  • 23

    Feb

CLVS Clovis
$34.76

-0.59 (-1.67%)

09/21/16
09/21/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Monsanto (MON) upgraded to Overweight from Neutral at JPMorgan with analyst Jeffrey Zekauskas saying the risk in the shares is "less than what the market assumes." 2. Barclays (BCS) upgraded to Buy from Hold at HSBC citing the pending disposal of non-core businesses and resulting value creation. 3. Etsy (ETSY) upgraded to Buy from Neutral at Monness Crespi with the firm's analyst believing that Etsy shares can still move higher and sees a solid opportunity for upward revisions from improving conversion rates due to enhanced search and mobile functionality, expanding take rates, and advanced cross-boarder commerce capabilities with vendors. 4. Clovis (CLVS) upgraded to Outperform from Neutral at Credit Suisse with analyst Kennen MacKay saying the potential for a takeover "outweighs concerns surrounding patent life, limited experience in platinum resistant/refractory patients, and PARPi competition." 5. Jabil Circuit (JBL) upgraded to Buy from Neutral at UBS with analyst Steven Milunovich saying the company's cash flow is nearing an inflection amid an upturn in its Apple (AAPL) business. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/21/16
JANY
09/21/16
DOWNGRADE
JANY
Neutral
Clovis downgraded to Neutral from Buy at Janney Capital
09/21/16
JANY
09/21/16
DOWNGRADE
Target $36
JANY
Neutral
Janney downgrades Clovis with buyout speculation at 'fever pitch'
Janney Capital analyst Roy Buchanan downgraded Clovis Oncology (CLVS) to Neutral from Buy with an increased fair value estimate of $36. Clovis is up 17c to $35.00 in late morning trading. In a research note partially titled, "May Be Right, May Be Crazy - M&A Speculation At Fever Pitch," Buchanan says there is a "finite chance" that Clovis will need to market its PARP inhibitor rucaparib by itself. He believes a late-2016 approval for rucaparib is likely. The analyst attributes his increased fair value estimate to "acquisition optionality." Reports of Takeda's (TKPYY) reserving up to $15B for acquisitions and Medivation's (MDVN) takeout have given Clovis shares a lift, Buchanan tells investors. The analyst adds that rumors surfaced yesterday of potential interest in the company from Eli Lilly (LLY).
10/04/16
PIPR
10/04/16
NO CHANGE
Target $42
PIPR
Neutral
Clovis price target raised to $42 from $14 at Piper Jaffray
Piper Jaffray analyst Steven Breazzano raised his price target for Clovis Oncology (CLVS) to $42 after taking a "comprehensive look" at the PARP inhibitor landscape in ovarian cancer and beyond. The company's PARP inhibitor rucaparib has demonstrated an active profile in ovarian cancer and all signs point to an approval in the 3L+ setting early next year, Breazzano tells investors in a research note. The analyst, however, believes the ultimate key is success in the earlier maintenance setting, and he thinks the race may still be Tesaro's (TSRO) niraparib's to lose. Breazzano keeps a Neutral rating on Clovis.

TODAY'S FREE FLY STORIES

ORCL

Oracle

$51.11

0.156 (0.31%)

11:28
06/26/17
06/26
11:28
06/26/17
11:28
Conference/Events
Oracle management to meet with Evercore ISI »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 28

    Jun

OXY

Occidental Petroleum

$59.84

-0.28 (-0.47%)

11:25
06/26/17
06/26
11:25
06/26/17
11:25
Conference/Events
Occidental Petroleum management to meet with Evercore ISI »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

HTZ

Hertz

$10.34

0.8046 (8.43%)

11:25
06/26/17
06/26
11:25
06/26/17
11:25
Options
Hertz call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BABA

Alibaba

$141.72

-1.31 (-0.92%)

11:24
06/26/17
06/26
11:24
06/26/17
11:24
Periodicals
Alibaba-backed Best Inc aiming to raise up to $750M in IPO, WWD reports »

Best Inc., a logistics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

NFG

National Fuel

$56.53

0.16 (0.28%)

11:22
06/26/17
06/26
11:22
06/26/17
11:22
Conference/Events
National Fuel management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 28

    Jun

NFG

National Fuel

$56.53

0.16 (0.28%)

11:22
06/26/17
06/26
11:22
06/26/17
11:22
Conference/Events
National Fuel management to meet with Evercore ISI »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 28

    Jun

FN

Fabrinet

$42.84

2.82 (7.05%)

, AAOI

Applied Optoelectronics

$65.87

2.29 (3.60%)

11:18
06/26/17
06/26
11:18
06/26/17
11:18
Hot Stocks
Fabrinet rises, Applied Optoelectronics sinks after Needham uncovers AWS deal »

Fabrinet (FN) has won a…

FN

Fabrinet

$42.84

2.82 (7.05%)

AAOI

Applied Optoelectronics

$65.87

2.29 (3.60%)

MTSI

MACOM

$58.26

1.76 (3.12%)

AMZN

Amazon.com

$1,003.74

2.44 (0.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 26

    Jun

  • 26

    Jun

  • 28

    Jun

  • 12

    Jul

  • 13

    Jul

  • 29

    Aug

ADNT

Adient

$64.75

0.62 (0.97%)

11:17
06/26/17
06/26
11:17
06/26/17
11:17
Conference/Events
Adient to hold a meeting »

EVP & CFO Stafeil,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 27

    Jul

ORCL

Oracle

$51.32

0.37 (0.73%)

, BAC

Bank of America

$22.83

0.0134 (0.06%)

11:17
06/26/17
06/26
11:17
06/26/17
11:17
Periodicals
Oracle signs BofA as customer for ERP, financial planning software, CNBC says »

Oracle (ORCL) signed Bank…

ORCL

Oracle

$51.32

0.37 (0.73%)

BAC

Bank of America

$22.83

0.0134 (0.06%)

SAP

SAP

$107.12

-0.36 (-0.33%)

AMZN

Amazon.com

$1,003.74

2.44 (0.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 26

    Jun

  • 28

    Jun

  • 28

    Jun

$NSD

NASDAQ Market Internals

11:17
06/26/17
06/26
11:17
06/26/17
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

11:16
06/26/17
06/26
11:16
06/26/17
11:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:15
06/26/17
06/26
11:15
06/26/17
11:15
General news
Treasury announced a $40 4-week bill sale for Tuesday »

Treasury announced a $40…

11:15
06/26/17
06/26
11:15
06/26/17
11:15
General news
Breaking General news story  »

6-Month Bill Auction to…

11:15
06/26/17
06/26
11:15
06/26/17
11:15
General news
Breaking General news story  »

3-Month Bill Auction to…

ARNC

Arconic

$23.86

-1.68 (-6.58%)

11:12
06/26/17
06/26
11:12
06/26/17
11:12
Periodicals
Arconic discontinuing global Reynobond PE sales for high-rise uses »

CNBC tweets that Arconic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARNC

Arconic

$23.99

-1.55 (-6.07%)

11:10
06/26/17
06/26
11:10
06/26/17
11:10
Periodicals
Breaking Periodicals news story on Arconic »

Arconic to limit sales of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RAD

Rite Aid

$3.11

-0.005 (-0.16%)

, WBA

Walgreens Boots Alliance

$76.34

-0.03 (-0.04%)

11:10
06/26/17
06/26
11:10
06/26/17
11:10
Hot Stocks
Rite Aid jumps after CTFN publishes report »

Shares of Rite Aid (RAD)…

RAD

Rite Aid

$3.11

-0.005 (-0.16%)

WBA

Walgreens Boots Alliance

$76.34

-0.03 (-0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

CAR

Avis Budget

$24.24

1.23 (5.35%)

11:10
06/26/17
06/26
11:10
06/26/17
11:10
Options
Higher volume in Avis fueled by talk about a deal with Google (GOOG) »

Higher volume in Avis…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PODD

Insulet

$49.38

0.58 (1.19%)

11:05
06/26/17
06/26
11:05
06/26/17
11:05
Conference/Events
Insulet participates in a conference call with Leerink »

Conference call with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$202.32

0.09 (0.04%)

, RYAAY

Ryanair

$109.06

-0.22 (-0.20%)

11:04
06/26/17
06/26
11:04
06/26/17
11:04
Hot Stocks
Boeing reports 153 new orders since last update »

Boeing (BA) on its…

BA

Boeing

$202.32

0.09 (0.04%)

RYAAY

Ryanair

$109.06

-0.22 (-0.20%)

UAL

United Continental

$77.13

0.34 (0.44%)

AER

AerCap

$45.81

0.17 (0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 07

    Jul

  • 26

    Jul

GRUB

GrubHub

$44.55

-3.1462 (-6.60%)

, AMZN

Amazon.com

$1,003.74

2.44 (0.24%)

11:04
06/26/17
06/26
11:04
06/26/17
11:04
Hot Stocks
Battleground: Analysts mull if Amazon more likely to beat, or buy, GrubHub »

In the wake of…

GRUB

GrubHub

$44.55

-3.1462 (-6.60%)

AMZN

Amazon.com

$1,003.74

2.44 (0.24%)

WFM

Whole Foods

$42.95

-0.255 (-0.59%)

YELP

Yelp

$30.29

-0.59 (-1.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 26

    Jun

  • 28

    Jun

V

Visa

$95.43

-0.15 (-0.16%)

11:00
06/26/17
06/26
11:00
06/26/17
11:00
Options
1x2 call spread in Visa tied to delta hedge »

1x2 call spread in Visa…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

11:00
06/26/17
06/26
11:00
06/26/17
11:00
General news
FX Action: USD-JPY »

FX Action: USD-JPY has…

PFSW

PFSweb

$7.66

-0.21 (-2.67%)

10:59
06/26/17
06/26
10:59
06/26/17
10:59
Conference/Events
PFSweb management to meet with Lake Street »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

10:55
06/26/17
06/26
10:55
06/26/17
10:55
General news
U.S. Dallas Fed manufacturing index slipped to 15.0 in June »

U.S. Dallas Fed…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.